xbird

Berlin, Germany Founded: 2015 • Age: 11 yrs Acquired By Glooko
Provider of AI-based solutions for diagnosis and health risk assessment

About xbird

xbird is a Healthcare company based in Berlin (Germany) founded in 2015, and was acquired by Glooko in January 2022. Provider of AI-based solutions for diagnosis and health risk assessment. xbird has raised $1.18 million across 2 funding rounds from investors including Glooko, IBB Ventures and Cascara Ventures. xbird offers products and services including xbird AI Platform and Glucose Monitoring Service. Its focus areas include HealthTech, Disease Self Management, Behavioural Health and Health Risk Assessment. Its legal entity is xbird GmbH.

Company details

xbird is a provider of AI-based solutions for diagnosis and health risk assessment. The medical AI company focuses on the prevention and early recognition of curable diseases. AI uses machine learning to detect patterns in behavior and aids in sticking to a fitnesshealth regimen.

Key Metrics
  • Total Equity Funding
    $1.18M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.18M (USD), Series A

    Aug 2020

  • Investors
    Glooko

    & 2 more

  • Acquired by
    Glooko

    (Jan 2022)

Products & Services of xbird

xbird offers a comprehensive portfolio of products and services, including xbird AI Platform and Glucose Monitoring Service.

xbird AI Platform
Health Monitoring

AI tool for diabetes data analysis and therapy personalization.

Glucose Monitoring Service
Medical Analytics

Platform for tracking blood glucose and predicting health risks.

Funding Insights of xbird

xbird has successfully raised a total of $1.18M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.18 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.18M
  • Total Rounds 2
  • Last Round Series A β€” $1.18M
  • Investors Count 2

All 2 funding rounds of xbird with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2020$1.18MSeries A–IBB Ventures
–
Jun 2016Series A––
Valuation history

3 investors in total: 3 institutional.

Investors in xbird

xbird has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Glooko, IBB Ventures and Cascara Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital firm focused on multiple sectors
ibbventures.deBerlin, Germany
Early-stage investments are provided by Cascara Ventures in life sciences.
2016cascaraventures.com
Diabetes management is enabled via glucose meters and mobile apps.
2010glooko.comPalo Alto, United States
Premium access

Investor details for xbird

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of xbird

5 people are tracked at xbird (1 in leadership, 4 in team).

NameRoleGroup
Elke Henning
Head, Finance, HR & OperationsLeadership
Silvia Cepeda García
Manager, Finance, HR & OperationsTeam
Aurimas Deimantas
Mobile Developer FlutterTeam
Christian Pisetta
Product ManagerTeam
Ezgi Birdal
Compliance OfficerTeam
Premium access

Complete people profiles for xbird

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of xbird

4 dated milestones of xbird across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded xbird is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A, of $1.2M.
  4. Exit Acquired by Glooko.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Xbird

Premium access

Complete news archive for xbird

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about xbird

xbird was founded in 2015 and raised its 1st funding round 1 year after it was founded.

xbird is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.

xbird is a funded company, having raised a total of $1.18M across 2 funding rounds to date.

xbird is a provider of AI-based solutions for diagnosis and health risk assessment. The medical AI company focuses on the prevention and early recognition of curable diseases. AI uses machine learning to detect patterns in behavior and aids in sticking to a fitnesshealth regimen.

xbird offers xbird AI Platform and Glucose Monitoring Service.

xbird has 3 investors. Key investors include Glooko, IBB Ventures, and Cascara Ventures.

xbird operates through Xbird Gmbh.

Yes. xbird was acquired by Glooko in January 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available